NCT00074672

Brief Summary

This study will explore what occurs between sensory and motor systems in restless legs syndrome (RLS). Patients with RLS have uncomfortable sensations in the legs, usually in the evening or early part of the night. Most patients also have periodic involuntary leg movements. The condition tends to worsen over time, resulting in severe discomfort and sleep disturbances. Healthy normal volunteers and patients with RLS between 18 and 80 years of age may be eligible for this study. All candidates will be screened with a medical history, physical and neurological evaluations, electroymogram (measure of muscle activity), overnight sleep study, electrocardiogram (ECG, measurement of the electrical activity of the heart), and blood and urine tests. They may also have brain or spine magnetic resonance imaging (MRI) or computerized tomography (CT) scans and a chest X-ray. Participants must stop taking all medications prohibited by the study for 2 days or more before the study starts and throughout its duration. Participants will undergo prepulse inhibition tests to assess nervous system function. The participant sits comfortably in a quiet room. Several cables are attached to the face and legs using a special cream that conducts electrical signals through the cables to recording equipment. Nervous system activity is evaluated while the subject is at rest and after sensory stimulation (stimulating the nerves in the legs and face with a very brief electrical current of mild to moderate intensity). At times, the subject receives a short, mild sound stimulation delivered through earphones. The testing session takes 4 to 6 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2003

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 17, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 18, 2003

Completed
5.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2009

Completed
Last Updated

July 2, 2017

Status Verified

April 14, 2009

First QC Date

December 17, 2003

Last Update Submit

June 30, 2017

Conditions

Keywords

Prepulse InhibitionPPIDopamineSensorimotor IntegrationDopaminergic

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female subjects aged 18 to 80.
  • For patients only, diagnosed with primary RLS based on the presence of a characteristic clinical history and the IRLSSG diagnostic criteria.
  • Normal physical and neurological examination.
  • Subject is willing to adhere to protocol requirements as evidenced by written, informed consent.
  • No clinically significant abnormalities on clinical chemistry or hematology examination at the pre-study medical evaluation.
  • Negative pre-study urine drug screen.

You may not qualify if:

  • History of any medical condition that can reasonably be expected to compromise scientific integrity of the study;
  • Patient unwilling or unable to stop their usual mediations for RLS;
  • Subjects unable or unwilling to discontinue a prohibited concomitant medication
  • Subjects unwilling to sign an informed consent or to comply with protocol requirements.
  • Subjects with clinical and/or biological evidence of secondary RLS (e.g. renal failure (end-stage renal disease), iron deficient, anaemia or pregnancy at baseline).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995 Sep;10(5):634-42. doi: 10.1002/mds.870100517.

    PMID: 8552117BACKGROUND
  • Silber MH. Restless legs syndrome. Mayo Clin Proc. 1997 Mar;72(3):261-4. doi: 10.4065/72.3.261.

    PMID: 9070203BACKGROUND
  • Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996 Dec;47(6):1435-41. doi: 10.1212/wnl.47.6.1435.

    PMID: 8960723BACKGROUND

MeSH Terms

Conditions

Restless Legs Syndrome

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental Disorders

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

December 17, 2003

First Posted

December 18, 2003

Study Start

December 12, 2003

Study Completion

April 14, 2009

Last Updated

July 2, 2017

Record last verified: 2009-04-14

Locations